PMID- 22538453 OWN - NLM STAT- MEDLINE DCOM- 20121130 LR - 20211021 IS - 1432-1335 (Electronic) IS - 0171-5216 (Linking) VI - 138 IP - 9 DP - 2012 Sep TI - A potential probe set of fluorescence in situ hybridization for detection of lung cancer in bronchial brushing specimens. PG - 1541-9 LID - 10.1007/s00432-012-1232-0 [doi] AB - PURPOSE: The study aims to find candidate probes of fluorescence in situ hybridization (FISH) for detection of lung cancer with bronchial brushings and to evaluate whether the accuracy of diagnosing lung cancer by cytological deviant and genetic abnormalities is greater than that of cytology alone. METHODS: Centromeric enumeration probes (CEPs) for chromosomes 2, 3, 6, 7, 8, 9, 11, 12, and 17 were analyzed using FISH in 74 surgical resection tissues, 32 operative margin tissues without tumor involvement of lung cancer, and 174 bronchial brushings. RESULTS: The aneuploidy rates of the tested probes were 61.7, 89.1, 80.0, 92.7, 65.0, 70.4, 66.7, 71.8, 68.9 % in tumor tissues, and 29.3, 58.9, 33.3, 69.6, 67.0, 40.3, 38.0, 49.3, 35.1 % in bronchial brushings. The combination of cytology and FISH using the three-probe set for chromosomes 3+7+8 significantly improved the sensitivity of bronchial brushing examination for lung cancer detection (P = 0.00003), especially squamous cell carcinoma (SCC), which increased from 78.0 to 98.2 %. The specificity of the 3+7+8 probe set was 94.6 %. Moreover, a high aneuploidy rate of the probe set in bronchial brushings was detected more often in SCCs (P = 0.029) and late-stage non-small-cell lung cancer (NSCLC) (P = 0.044). Kaplan-Meier curves indicated that adenocarcinoma (ADC) patients with high aneuploidy rate of CEP3 in tissue samples exhibited poorer overall survival (P = 0.016). CONCLUSIONS: FISH performed on cytology preparations is useful for confirmation of cancer diagnosis. The three-probe set, 3+7+8, has potential value for the detection of SCCs in bronchial brushings. FAU - Liu, Yi-Zhen AU - Liu YZ AD - State Key Laboratory of Molecular Oncology, Cancer Institute/Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. FAU - Wang, Zhen AU - Wang Z FAU - Fang, Li-Li AU - Fang LL FAU - Li, Lu AU - Li L FAU - Cao, Jian AU - Cao J FAU - Xu, Xin AU - Xu X FAU - Han, Ya-Ling AU - Han YL FAU - Cai, Yan AU - Cai Y FAU - Wang, Liang-Xu AU - Wang LX FAU - Wang, Ming-Rong AU - Wang MR LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120427 PL - Germany TA - J Cancer Res Clin Oncol JT - Journal of cancer research and clinical oncology JID - 7902060 RN - 0 (DNA Probes) SB - IM CIN - Expert Rev Mol Diagn. 2012 Sep;12(7):679-81. PMID: 23153235 MH - Adenocarcinoma/diagnosis/genetics MH - Adult MH - Aged MH - Aged, 80 and over MH - Aneuploidy MH - Bronchi/metabolism/pathology MH - Carcinoma, Non-Small-Cell Lung/diagnosis/genetics MH - Carcinoma, Squamous Cell/diagnosis/genetics MH - Centromere/genetics MH - Chromosomes, Human, Pair 3/genetics MH - Chromosomes, Human, Pair 7/genetics MH - Chromosomes, Human, Pair 8/genetics MH - DNA Probes/*genetics MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence/*methods MH - Kaplan-Meier Estimate MH - Lung Neoplasms/*diagnosis/*genetics MH - Male MH - Middle Aged MH - Prognosis MH - Sensitivity and Specificity EDAT- 2012/04/28 06:00 MHDA- 2012/12/10 06:00 CRDT- 2012/04/28 06:00 PHST- 2012/02/09 00:00 [received] PHST- 2012/04/10 00:00 [accepted] PHST- 2012/04/28 06:00 [entrez] PHST- 2012/04/28 06:00 [pubmed] PHST- 2012/12/10 06:00 [medline] AID - 10.1007/s00432-012-1232-0 [doi] PST - ppublish SO - J Cancer Res Clin Oncol. 2012 Sep;138(9):1541-9. doi: 10.1007/s00432-012-1232-0. Epub 2012 Apr 27.